Does TALAZOPARIB Cause Febrile neutropenia? 60 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Febrile neutropenia have been filed in association with TALAZOPARIB (Talzenna). This represents 4.1% of all adverse event reports for TALAZOPARIB.
60
Reports of Febrile neutropenia with TALAZOPARIB
4.1%
of all TALAZOPARIB reports
9
Deaths
52
Hospitalizations
How Dangerous Is Febrile neutropenia From TALAZOPARIB?
Of the 60 reports, 9 (15.0%) resulted in death, 52 (86.7%) required hospitalization, and 5 (8.3%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for TALAZOPARIB.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Pancytopenia (60)
Nausea (53)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which TALAZOPARIB Alternatives Have Lower Febrile neutropenia Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS